Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...
The Economist23h
Competition will make weight-loss drugs better, cheaper and bigger
A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...
Exclusive: Weight-loss drugs didn't curb health costs within two years, data show
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...
Study finds high costs, few benefits associated with GLP-1 weight loss drugs
New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...
The Financial Express21h
Data shows weight-loss drugs didn’t curb health costs within two years: Report
Prime Therapeutics reviewed pharmacy and medical claims data for 3,046 people with commercial health plans that cover GLP-1 ...
Heartland16h
Use of Weight Loss Drug Widespread, and Costly
As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...
Weight-loss medication helps mom manage her obesity. Province won’t pay for any of it
Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.
Expect health insurance costs to rise — again — for employers in 2025
Nationally, employers could see total health insurance costs rise 5.8% on average in 2025. KC won't be spared costlier ...
Fact check: Weight loss drug trial, US election rules and ‘IDF soldiers’ image
The government will not be paying the pharmaceutical firm Lilly £280 million to run a widely reported five-year trial into ...
HealthDay on MSN16h
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42 ...